Abstract
Recently, it has been recognized that cell-bound heparan sulfate (HS) proteoglycans (HSPG) are able to bind and subsequently initiate degradation of lipoproteins. Two mediators of lipoprotein catabolism, both with HS binding capacity, lipoprotein lipase (LPL) and apolipoprotein E (apoE), are involved in this process. This mechanism is known as the secretion-capture process of apoE. Lipoprotein(a) [Lp(a)] was shown to have a strong binding capacity to cell-associated HSPG. This binding capacity was increased by LPL addition. We investigated the effects of recombinant apoE (r-apoE) enrichment of Lp(a) on the binding to HS. Lp(a), isolated by ultracentrifugation and gel filtration, was incubated with r-apoE and reisolated by ultracentrifugation, resulting in r-apoE-enriched Lp(a). ApoE-enriched Lp(a) and control Lp(a) were coated to microtiter plates. The capacity to bind biotin-conjugated HS (b-HS) in the presence or absence of inactivated bovine LPL was studied. R-apoE-enriched Lp(a) showed increased b-HS binding capacity versus control Lp(a). Addition of LPL resulted in an increased b-HS binding capacity of both control and r-apoE-enriched Lp(a). To investigate whether binding of Lp(a) to endothelial cell HSPG occurred in vivo,...Continue Reading
References
Jun 15, 1978·Analytical Biochemistry·M A MarkwellN E Tolbert
May 12, 1975·Analytical Biochemistry·T G RedgraveC E West
Sep 16, 1975·Clinica Chimica Acta; International Journal of Clinical Chemistry·J K HuttunenE A Nikkilä
Jul 29, 1992·Biochimica Et Biophysica Acta·J M BardJ C Fruchart
Jun 1, 1992·Journal of Internal Medicine·A M Scanu
Aug 1, 1991·The Journal of Clinical Investigation·A K SoutarB L Knight
Oct 1, 1991·The Journal of Clinical Investigation·K J WilliamsT L Swenson
Jun 1, 1990·The Journal of Clinical Investigation·A M Scanu, G M Fless
Apr 20, 1989·The New England Journal of Medicine·R H Eckel
Jan 1, 1989·Annals of the New York Academy of Sciences·J A Marcum, R D Rosenberg
Jan 1, 1989·Annals of the New York Academy of Sciences·K OkaW V Brown
Nov 12, 1987·Nature·J W McLeanR M Lawn
Oct 1, 1983·Archives of Biochemistry and Biophysics·I PosnerW J McConathy
Mar 1, 1995·The Journal of Clinical Investigation·D J RaderM Grossman
Sep 10, 1994·Annals of the New York Academy of Sciences·R W MahleyD He
Apr 1, 1994·Current Opinion in Lipidology·A Gaw, H H Hobbs
May 1, 1994·The Journal of Clinical Investigation·H ShimanoN Yamada
Jun 1, 1994·The Journal of Clinical Investigation·D J RaderH B Brewer
Feb 1, 1994·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·M KawamuraK Kozaki
Jul 5, 1993·FEBS Letters·W MärzW Gross
Jun 1, 1993·Metabolism: Clinical and Experimental·M Castro CabezasD W Erkelens
Mar 1, 1996·Atherosclerosis·H H van BarlingenT W de Bruin
Jan 1, 1963·Acta Pathologica Et Microbiologica Scandinavica·K BERG
Citations
Apr 9, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·V MooserP Nicod
Oct 7, 2004·Journal of Lipid Research·Sung-Joon LeeAllen D Cooper
Sep 10, 2005·Journal of Lipid Research·William J CainDaniel J Rader
Apr 1, 2000·Annals of Internal Medicine·V MooserP Amouyel
Jul 26, 2014·The American Journal of Cardiology·Daniel GaudetEvan A Stein
Jul 14, 2005·Chemical Reviews·John M Whitelock, Renato V Iozzo
Dec 21, 2013·The Journal of Physical Chemistry. B·Consuelo N BeecherCynthia K Larive